KYOWA HAKKO BIO CO.,LTD.
KYOWA HAKKO BIO CO., LTD., a prominent player in the biotechnology industry, is headquartered in Tokyo, Japan, with significant operations across Asia, Europe, and North America. Founded in 1949, the company has established itself as a leader in the development and production of amino acids, fermentation products, and other biochemicals, catering to diverse sectors such as food, pharmaceuticals, and cosmetics. Renowned for its innovative approach, KYOWA HAKKO BIO offers unique products that enhance nutritional value and functionality, setting them apart in a competitive market. The company has achieved notable milestones, including advancements in fermentation technology and a strong commitment to sustainability. With a robust market position, KYOWA HAKKO BIO continues to drive growth and innovation, solidifying its reputation as a trusted partner in the global biotechnology landscape.
DitchCarbon Score
How does KYOWA HAKKO BIO CO.,LTD.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Computer Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
KYOWA HAKKO BIO CO.,LTD.'s score of 39 is higher than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.
KYOWA HAKKO BIO CO.,LTD.'s reported carbon emissions
In 2023, KYOWA HAKKO BIO CO., LTD. reported total carbon emissions of approximately 305,000 tonnes CO2e. This figure includes 33,000 tonnes from Scope 1 emissions, 96,000 tonnes from Scope 2, and 176,000 tonnes from Scope 3 emissions. Over the past few years, the company has demonstrated a commitment to reducing its carbon footprint, with emissions decreasing from about 363,000 tonnes CO2e in 2022 and 392,000 tonnes CO2e in 2021. Despite these reductions, KYOWA HAKKO BIO has not publicly set specific reduction targets or initiatives under frameworks such as the Science Based Targets Initiative (SBTi) or the Carbon Disclosure Project (CDP). The absence of formal reduction commitments suggests that while the company is actively monitoring and reporting its emissions, it may not yet have established a comprehensive strategy for long-term climate action. Overall, KYOWA HAKKO BIO's emissions data reflects a positive trend towards lower carbon emissions, aligning with broader industry efforts to mitigate climate change impacts.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project2005 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Scope 1 | 601,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 |
| Scope 3 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
KYOWA HAKKO BIO CO.,LTD. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
